Single Cell mRNA Quantification via Chaotropic Lysis and RT-PCR

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for single cell mRNA analysis are limited in sensitivity, making it difficult to detect low-level target mRNAs, and are not effective for analyzing small numbers of cells or individual cells, leading to loss of important information about cell heterogeneity and gene expression variability.

Innovation Solution

A method involving lysis with a chaotropic agent, followed by reverse transcription and real-time PCR amplification without intermediate purification, using a mixture of primers hybridizing to poly-A sequences and random primers, optimized for samples containing only a few or single cells, with specific conditions for temperature and chaotropic agent concentration to enhance mRNA accessibility and amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional RT-PCR methods are used for single cell mRNA analysis, then the method is simple to operate, but the sensitivity is insufficient to detect low-level target mRNAs

Engineering Contradiction:
Improvedetection sensitivityVSAvoidprotocol complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The method performs preliminary actions by optimizing lysis buffer composition (containing chaotropic agents, detergents, and reducing agents) and reverse transcription conditions before the actual PCR amplification. This pre-optimization includes cell permeabilization, RNA extraction, and cDNA synthesis in a single step, preparing the sample in advance to enhance detection sensitivity without requiring complex intermediate processing steps.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention changes key parameters including using chaotropic agents (guanidine thiocyanate, guanidine hydrochloride) at specific concentrations, optimizing detergent types and amounts, adjusting reducing agent concentrations, and controlling incubation temperatures and times. These parameter optimizations collectively enhance the sensitivity of low-level mRNA detection while maintaining protocol simplicity.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If intermediate purification steps are added to improve mRNA detection accuracy, then measurement precision improves, but operation complexity and time increase

Engineering Contradiction:
ImprovemRNA quantification accuracyVSAvoidprotocol simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The method merges multiple steps including cell lysis, RNA extraction, and reverse transcription into a single unified reaction mixture. The lysis buffer contains all necessary components (chaotropic agents, detergents, reducing agents, primers, and reverse transcriptase) to perform these functions simultaneously without intermediate purification steps, maintaining both simplicity and accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The lysis buffer serves multiple functions: it permeabilizes cells, extracts RNA, protects RNA from degradation, and provides optimal conditions for reverse transcription. This multi-functional buffer system eliminates the need for separate purification steps while maintaining mRNA quantification accuracy through optimized composition.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Loss of information

If the method is optimized for single cells or small cell populations, then cell heterogeneity analysis improves, but the quantity of sample required decreases making detection more difficult

Engineering Contradiction:
Improvecell heterogeneity informationVSAvoidmRNA amount
Core Design Contradiction:
Loss of informationVSQuantity of substance

Solution Approach 1:

The method uses parameter changes including high concentrations of chaotropic agents to denature proteins and release RNA, optimized detergent concentrations to solubilize membranes, and extended incubation times to ensure complete extraction from minimal cells. These changes enable efficient RNA recovery from single cells or small populations while preserving heterogeneity information.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces mechanical disruption methods with chemical lysis using optimized buffer compositions. The chaotropic agents and detergents chemically permeabilize cells and release RNA without requiring physical homogenization, making the method suitable for single cells where mechanical forces would be damaging or ineffective.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for accurate and sensitive gene expression profiling in single cells or small cell populations, enabling the detection of low-level transcripts and providing insights into cell-to-cell variability and gene induction, with improved reproducibility and accuracy in quantifying mRNA levels.

Implementation Method 1

lysis of a biological sample consisting of only a few cells which is supposed to contain said target RNA with a lysis buffer comprising between 0.05 M and 1 M Chaotropic agent

Methodology Applied
Scientific EffectChaotropic effect:

Implementation Method 2

reverse transcribing said target RNA in the presence of a mixture of first strand cDNA synthesis primers

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Implementation Method 3

subjecting said sample to multiple cycles of a thermocycling protocol and monitoring amplification of said first strand cDNA

Methodology Applied
Scientific EffectPCR amplification: Enzyme

Data Source

PatentUS8642266B2Single cell MRNA quantification with real-time RT-PCR
Publication Date: 2014.02.04 TATAA BIOCENT
  • US8642266B2 patent drawing
  • US8642266B2 patent drawing
  • US8642266B2 patent drawing

AI summary

The present invention is directed to a method for performing an RT-PCR for amplifying a target RNA comprising the steps of a) lysis of a cellular sample which is supposed to contain the target RNA with a lysis buffer comprising between 0.2 M and 1 M guanidine thiocyanate, b) diluting the sample to an extend such that guanidine thiocyanate is present in a concentration of about 30 to 50 mM, c) reverse transcribing in the presence of a mixture of first strand cDNA synthesis primers, the mixture consisting of oligo dT primers and random primers, and d) subjecting the sample to multiple cycles of a thermocycling protocol and monitoring amplification of the first strand cDNA in real time.